This document is an excerpt from the EUR-Lex website
Document 22024D1009
Decision of the EEA joint committee No 235/2023 of 22 September 2023 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1009]
Decision of the EEA joint committee No 235/2023 of 22 September 2023 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1009]
Decision of the EEA joint committee No 235/2023 of 22 September 2023 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1009]
OJ L, 2024/1009, 25.4.2024, ELI: http://data.europa.eu/eli/dec/2024/1009/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
Date of entry into force unknown (pending notification) or not yet in force.
|
Official Journal |
EN L series |
|
2024/1009 |
25.4.2024 |
DECISION OF THE EEA JOINT COMMITTEE No 235/2023
of 22 September 2023
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2024/1009]
THE EEA JOINT COMMITTEE,
Having regard to the Agreement on the European Economic Area (“the EEA Agreement”), and in particular Article 98 thereof,
Whereas:
|
(1) |
Commission Implementing Decision (EU) 2023/458 of 1 March 2023 on the non-approval of certain active substances for use in biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (1) is to be incorporated into the EEA Agreement. |
|
(2) |
Commission Implementing Decision (EU) 2023/459 of 2 March 2023 not approving 2,2-Dibromo-2-cyanoacetamide (DBNPA) as an existing active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (2) is to be incorporated into the EEA Agreement. |
|
(3) |
Commission Implementing Decision (EU) 2023/460 of 2 March 2023 postponing the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (3) is to be incorporated into the EEA Agreement. |
|
(4) |
Annex II to the EEA Agreement should therefore be amended accordingly, |
HAS ADOPTED THIS DECISION:
Article 1
The following points are inserted after point 12zzzzzzzzz (Commission Implementing Regulation (EU) 2022/1991) of Chapter XV of Annex II to the EEA Agreement:
|
‘12zzzzzzzzza. |
32023 D 0458: Commission Implementing Decision (EU) 2023/458 of 1 March 2023 on the non-approval of certain active substances for use in biocidal products in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 67, 3.3.2023, p. 51). |
|
12zzzzzzzzzb. |
32023 D 0459: Commission Implementing Decision (EU) 2023/459 of 2 March 2023 not approving 2,2-Dibromo-2-cyanoacetamide (DBNPA) as an existing active substance for use in biocidal products of product-type 4 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 67, 3.3.2023, p. 54). |
|
12zzzzzzzzzc. |
32023 D 0460: Commission Implementing Decision (EU) 2023/460 of 2 March 2023 postponing the expiry date of the approval of imidacloprid for use in biocidal products of product-type 18 in accordance with Regulation (EU) No 528/2012 of the European Parliament and of the Council (OJ L 67, 3.3.2023, p. 58).’ |
Article 2
The texts of Implementing Decisions (EU) 2023/458, (EU) 2023/459 and (EU) 2023/460 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.
Article 3
This Decision shall enter into force on 23 September 2023, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*1).
Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.
Done at Brussels, 22 September 2023.
For the EEA Joint Committee
The President
Pascal SCHAFHAUSER
(*1) No constitutional requirements indicated.
ELI: http://data.europa.eu/eli/dec/2024/1009/oj
ISSN 1977-0677 (electronic edition)